Thienopyridine

DRUG4 trials

Sponsors

Boston Scientific Corporation, Teikyo University

Conditions

Coronary Artery Disease

Phase 3

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions

CompletedNCT00823212

Boston Scientific CorporationCoronary Artery Disease

Start: 2009-01-31End: 2014-12-31Updated: 2019-03-27

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

CompletedNCT01500434

Boston Scientific CorporationCoronary Artery Disease

Start: 2009-02-28End: 2015-05-31Updated: 2019-03-26

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)

CompletedNCT01510327

Boston Scientific CorporationCoronary Artery Disease

Start: 2009-10-31End: 2015-05-31Updated: 2019-03-26

Unknown Phase

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation

Teikyo UniversityCoronary Artery Disease

Start: 2016-07-31End: 2019-03-31Target: 1500Updated: 2016-08-02

Related Papers

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.

2017-12-0121 citations